COMMUNIQUÉS West-GlobeNewswire

Canada’s Leading Cannabis Health Care Service Signs First-of-its-kind Agreement with Durham College

15/01/2018 - 14:00

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, Jan. 15, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV:EMC) (EMC.WT) (“Emblem” or the “Company”) , on behalf of [...]

Extendicare Announces January 2018 Dividend of C$0.04 per Share

15/01/2018 - 14:00

MARKHAM, Ontario, Jan. 15, 2018 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE ) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the “Common [...]

REPEAT: Cannabis Wheaton Income Corp. Launches Kolab Project

15/01/2018 - 13:30

VANCOUVER, British Columbia, Jan. 15, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (d/b/a Wheaton Income) (TSX-V: CBW ) (" Wheaton Income " or the " Company ") is excited to launch KoLab Project Inc. (“ KoLab [...]

Renaissance BioScience Corp. Retains Blair Jordan as Capital Markets Advisor

15/01/2018 - 13:00

VANCOUVER, British Columbia, Jan. 15, 2018 (GLOBE NEWSWIRE) -- Renaissance BioScience Corp., a leading global yeast technology company, is pleased to announce that it has strengthened its capital markets team with the [...]

MPX Signs Agreement With Israeli Pharmaceutical Company Panaxia for the Production and Marketing of Pharma-Grade Cannabinoid Products

15/01/2018 - 13:00

TORONTO, Jan. 15, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (the “ Company ” or “ MPX ”) (CSE:MPX) (OTC:MPXEF) today announced that further to its press release dated August 22, 2017, it has entered into a [...]

Avivagen Announces Positive Results from Swine Trial

15/01/2018 - 12:30

OTTAWA, Jan. 15, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“Avivagen” or the “Corporation”), a Corporation with a proven and commercially-ready, patent-protected product intended to replace the [...]

Cytovance® Biologics Welcomes Edwin Miranda as Vice President of Quality

15/01/2018 - 10:00

OKLAHOMA CITY, Jan. 15, 2018 (GLOBE NEWSWIRE) -- Cytovance® Biologics, Inc., a leading full-service biopharmaceutical contract manufacturer of mammalian and microbial biologics, announces and welcomes Edwin Miranda as [...]

Xbrane Biopharma clarifies information regarding letter of intent with CR Pharma considering Xlucane

15/01/2018 - 09:39

Press release 2018-01-15 Xbrane Biopharma ("Xbrane" or the "Company") signed the 7 th of December 2017 a non-binding letter of intent with the Chinese pharmaceutical company CR Pharma regarding out-licensing of Xlucane [...]

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

15/01/2018 - 09:01

FIT Biotech Oy Company release January 15, 2018 at 10:00 AM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on September 26, 2016 [...]

Immunicum AB (publ) Initiates Trading of Shares on Nasdaq Stockholm

15/01/2018 - 08:46

Press Release 15 January 2018 Immunicum AB (publ) Initiates Trading of Shares on Nasdaq Stockholm Immunicum AB (publ), a biopharmaceutical company advancing a novel immuno-oncology treatment against a range of solid [...]

Shire granted EU marketing authorization for ADYNOVI® [Antihemophilic Factor (Recombinant), PEGylated] for adults and adolescents with Hemophilia A

15/01/2018 - 08:00

Shire granted EU marketing authorization for ADYNOVI ® [Antihemophilic Factor (Recombinant), PEGylated] for adults and adolescents with Hemophilia A Marketing Authorization will enable patient access to ADYNOVI [...]

TiGenix announces publication in Gastroenterology of 52-week results of the Phase III ADMIRE-CD trial of Cx601

15/01/2018 - 07:01

PRESS RELEASE TiGenix announces publication in Gastroenterology of 52-week results of the Phase III ADMIRE-CD trial of Cx601 Leuven (BELGIUM) - January 15, 2018, 07:00 CET - TiGenix NV (Euronext Brussels and NASDAQ: TIG [...]

TiGenix annonce la publication dans Gastroenterology des résultats de la semaine 52 de l'essai de phase III ADMIRE-CD du Cx601

15/01/2018 - 07:01

COMMUNIQUÉ DE PRESSE TiGenix annonce la publication dans Gastroenterology des résultats de la semaine 52 de l'essai de phase III ADMIRE-CD du Cx601 Louvain (BELGIQUE) - 15 janvier 2018, 07h. CET - TiGenix NV (Euronext [...]

Cannabis Wheaton Income Corp. Launches Kolab Project

15/01/2018 - 06:01

VANCOUVER, British Columbia, Jan. 15, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (d/b/a Wheaton Income) (TSX-V: CBW ) (" Wheaton Income " or the " Company ") is excited to launch KoLab Project Inc. (“ KoLab [...]

Telix Pharmaceuticals Establishes Japanese Subsidiary, Appoints Key Executives

15/01/2018 - 03:12

MELBOURNE, Australia and KYOTO Japan, Jan. 15, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the development of diagnostic [...]

Nova Leap Health Corp. Grants Stock Options

12/01/2018 - 23:56

HALIFAX, Novia Scotia, Jan. 12, 2018 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV:NLH) ("Nova Leap" or the "Company"), a company focused on the home health care industry, has granted 1,485,000 incentive stock [...]

TESARO Announces Updates to the U.S. Prescribing Information for VARUBI® (rolapitant) Injectable Emulsion

12/01/2018 - 23:30

WALTHAM, Mass., Jan. 12, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ: TSRO ), an oncology-focused biopharmaceutical company, today announced that it has updated the VARUBI® (rolapitant) injectable emulsion package [...]

Loop Industries Announces Net Loss of $6.7 million for the Third Quarter 2018, including $4.4 million Non-Cash Compensation Costs

12/01/2018 - 22:05

Pilot Plant Expansion to Increase Capacity and Demonstrate Continuous Operations Private Common Stock Issuance of $7 .4 million MONTREAL, Jan. 12, 2018 (GLOBE NEWSWIRE) -- Loop™ Industries, Inc. (NASDAQ: LOOP ) (the “ [...]

Transparency notifications pursuant to Article 14 of the Law of May 2, 2007

12/01/2018 - 22:01

REGULATED INFORMATION PRESS RELEASE Transparency notifications pursuant to Article 14 of the Law of May 2, 2007 Leuven (Belgium) - January 12, 2018, 22:00h CET - TiGenix NV (Euronext Brussels and Nasdaq: TIG; "TiGenix [...]